Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
Journal of Interventional Cardiology|February 16, 2007
Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registryJohn J Young, David A Cox, Thomas Stuckey, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2011
Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programmeMichael S Lee, Tae Yang, John M Lasala, et al.
Diabetes, Obesity & Metabolism|August 31, 2021
Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11Juan P Frias, Enzo Bonora, David A Cox, et al.
The American Journal of Cardiology|August 30, 2008
A clinical risk score for prediction of stent thrombosisKenneth W Baran, John M Lasala, David A Cox, et al.
JAMA|February 20, 2002
Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trialElizabeth Barrett-Connor, Deborah Grady, Andreas Sashegyi, et al.
Menopause (New York, N.Y.)|October 14, 2011
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone massSteven R Goldstein, Harjit Pal Bhattoa, Patrick Neven, et al.
JACC. Cardiovascular Interventions|July 24, 2010
Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) programEmmanouil S Brilakis, John M Lasala, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 14, 2012
Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus non-US sites? Analysis from the ACUITY trialPatrick Tobbia, Bruce R Brodie, Thomas Stuckey, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 26, 2003
Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X-TRACT) studyGregg W Stone, David A Cox, Reginald Low, et al.
Diabetes Care|July 2, 2024
Dulaglutide and Glomerular Hyperfiltration, Proteinuria, and Albuminuria in Youth With Type 2 Diabetes: Post Hoc Analysis of the AWARD-PEDS StudyPetter Bjornstad, Silva A Arslanian, Tamara S Hannon, et al.
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
Journal of Interventional Cardiology|February 16, 2007
Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registryJohn J Young, David A Cox, Thomas Stuckey, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2011
Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programmeMichael S Lee, Tae Yang, John M Lasala, et al.
Diabetes, Obesity & Metabolism|August 31, 2021
Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11Juan P Frias, Enzo Bonora, David A Cox, et al.
The American Journal of Cardiology|August 30, 2008
A clinical risk score for prediction of stent thrombosisKenneth W Baran, John M Lasala, David A Cox, et al.
JAMA|February 20, 2002
Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trialElizabeth Barrett-Connor, Deborah Grady, Andreas Sashegyi, et al.
Menopause (New York, N.Y.)|October 14, 2011
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone massSteven R Goldstein, Harjit Pal Bhattoa, Patrick Neven, et al.
JACC. Cardiovascular Interventions|July 24, 2010
Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) programEmmanouil S Brilakis, John M Lasala, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 14, 2012
Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus non-US sites? Analysis from the ACUITY trialPatrick Tobbia, Bruce R Brodie, Thomas Stuckey, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 26, 2003
Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X-TRACT) studyGregg W Stone, David A Cox, Reginald Low, et al.
Diabetes Care|July 2, 2024
Dulaglutide and Glomerular Hyperfiltration, Proteinuria, and Albuminuria in Youth With Type 2 Diabetes: Post Hoc Analysis of the AWARD-PEDS StudyPetter Bjornstad, Silva A Arslanian, Tamara S Hannon, et al.
Pageof 17